• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5115928)   Today's Articles (45)
For: Blum KA. Upcoming diagnostic and therapeutic developments in classical Hodgkin's lymphoma. Hematology Am Soc Hematol Educ Program 2010;2010:93-100. [PMID: 21239777 DOI: 10.1182/asheducation-2010.1.93] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Number Cited by Other Article(s)
1
Pham A, Chen R. Brentuximab vedotin for the treatment of Hodgkin’s lymphoma. Expert Rev Hematol 2015;8:403-12. [DOI: 10.1586/17474086.2015.1044432] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
2
Cerci JJ, Linardi CCG, Pracchia LF, Junior JS, Trindade E, Delbeke D, Cerci RJ, Carr R, Meneghetti JC, Buccheri V. 2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography initial staging impacts on survival in Hodgkin lymphoma. World J Radiol 2013;5:484-490. [PMID: 24379935 PMCID: PMC3874505 DOI: 10.4329/wjr.v5.i12.484] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2013] [Revised: 10/17/2013] [Accepted: 12/11/2013] [Indexed: 02/06/2023]  Open
3
van de Donk NWCJ, Dhimolea E. Brentuximab vedotin. MAbs 2012;4:458-65. [PMID: 22684302 PMCID: PMC3499340 DOI: 10.4161/mabs.20230] [Citation(s) in RCA: 104] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]  Open
4
Ramchandren R. Advances in the treatment of relapsed or refractory Hodgkin's lymphoma. Oncologist 2012;17:367-76. [PMID: 22387318 PMCID: PMC3316922 DOI: 10.1634/theoncologist.2011-0258] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2011] [Accepted: 12/28/2011] [Indexed: 01/07/2023]  Open
5
Tsukasaki K, Tobinai K, Hotta T, Shimoyama M. Lymphoma Study Group of JCOG. Jpn J Clin Oncol 2011;42:85-95. [DOI: 10.1093/jjco/hyr168] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
6
How we treat elderly patients with Hodgkin lymphoma. Curr Opin Oncol 2011;23:421-8. [DOI: 10.1097/cco.0b013e328348c6c1] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA